Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 14.12 USD -3.35% Market Closed
Market Cap: $467.1m

Relative Value

The Relative Value of one NPCE stock under the Base Case scenario is 11.1 USD. Compared to the current market price of 14.12 USD, Neuropace Inc is Overvalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NPCE Relative Value
Base Case
11.1 USD
Overvaluation 21%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

NPCE Competitors Multiples
Neuropace Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Neuropace Inc
NASDAQ:NPCE
474.1m USD 4.7 -21.8 -28.9 -28.5
US
Abbott Laboratories
NYSE:ABT
187.8B USD 4.2 28.8 16.5 22.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
170.2B USD 16.9 59.6 45.2 55.5
US
Stryker Corp
NYSE:SYK
129B USD 5.1 39.7 20.3 24.5
IE
Medtronic PLC
NYSE:MDT
112.1B USD 3.2 24.3 13.4 19.6
US
Boston Scientific Corp
NYSE:BSX
101.7B USD 5.1 35.1 20.6 27.7
DE
Siemens Healthineers AG
XETRA:SHL
43.9B EUR 1.9 20.8 11.6 16.3
US
Edwards Lifesciences Corp
NYSE:EW
49.1B USD 8.1 45.8 25.2 27.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.5B USD 10.6 43 30.6 33.8
US
Becton Dickinson and Co
NYSE:BDX
45.5B USD 2.1 25.9 10.2 17.2
US
Resmed Inc
NYSE:RMD
33.9B USD 6.3 22.8 16 17.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Neuropace Inc
NASDAQ:NPCE
Average EV/EBITDA: 21
Negative Multiple: -28.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
11%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.2
23%
2
US
Stryker Corp
NYSE:SYK
20.3
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.4
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.6
18%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
11.6
10%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
25.2
14%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.6
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
10.2
1%
10.2
US
Resmed Inc
NYSE:RMD
16
11%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Neuropace Inc
NASDAQ:NPCE
Average EV/EBIT: 26.3
Negative Multiple: -28.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.7
18%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.5
25%
2.2
US
Stryker Corp
NYSE:SYK
24.5
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.6
17%
1.2
US
Boston Scientific Corp
NYSE:BSX
27.7
26%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
16.3
15%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
27.6
15%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.8
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
17.2
15%
1.1
US
Resmed Inc
NYSE:RMD
17.8
12%
1.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett